In this work, PLGA-based biodegradable polymeric nanoparticles were synthetized, optimized and characterized for the encapsulation of S14, a potent PDE7 inhibitor, as a novel strategy for the treatment of Parkinson’s disease. Here, PDE7A is linked to Parkinson disease.